Alpha Cognition Q1 EPS Forecast Decreased by HC Wainwright

Key Points

• HC Wainwright cut Alpha Cognition's Q1 2026 EPS estimate to ($0.28) from ($0.24) and lowered FY2026 to ($1.09) while maintaining a Buy rating and an $18 price target.
• Wall Street Zen downgraded Alpha Cognition to a "sell" on April 4, though MarketBeat data still shows an average analyst rating of "Buy" and an average price target of $18.00.
• Alpha Cognition recently missed the quarter with ($0.30) EPS and $2.6M revenue (vs. $4.41M expected), has a negative net margin of 202.23%, and its shares opened at $6.38 (down ~3.9%) with a market cap of about $139M.

Alpha Cognition Inc. (NASDAQ:ACOG - Free Report) - Analysts at HC Wainwright dropped their Q1 2026 EPS estimates for Alpha Cognition in a research report issued on Wednesday, April 8th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($0.28) per share for the quarter, down from their previous forecast of ($0.24). HC Wainwright currently has a "Buy" rating and a $18.00 target price on the stock. HC Wainwright also issued estimates for Alpha Cognition's Q3 2026 earnings at ($0.29) EPS, Q4 2026 earnings at ($0.20) EPS, FY2026 earnings at ($1.09) EPS, Q1 2027 earnings at ($0.20) EPS, Q3 2027 earnings at ($0.04) EPS, Q4 2027 earnings at ($0.01) EPS and FY2027 earnings at ($0.35) EPS.

Separately, Wall Street Zen downgraded shares of Alpha Cognition from a "hold" rating to a "sell" rating in a report on Saturday, April 4th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, Alpha Cognition presently has an average rating of "Buy" and an average price target of $18.00.

Alpha Cognition Stock Down 3.9%

Shares of NASDAQ:ACOG opened at $6.38 on Friday. The company has a market cap of $138.89 million, a price-to-earnings ratio of -5.50 and a beta of 2.51. The firm's 50-day simple moving average is $5.64 and its 200-day simple moving average is $6.09. Alpha Cognition has a fifty-two week low of $3.97 and a fifty-two week high of $11.54.

Alpha Cognition (NASDAQ:ACOG - Get Free Report) last issued its earnings results on Thursday, March 26th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The firm had revenue of $2.60 million during the quarter, compared to analysts' expectations of $4.41 million. Alpha Cognition had a negative net margin of 202.23% and a negative return on equity of 55.71%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Green Alpha Advisors LLC acquired a new position in Alpha Cognition during the fourth quarter worth about $72,000. Geode Capital Management LLC acquired a new position in Alpha Cognition during the second quarter worth about $112,000. Massar Capital Management LP purchased a new stake in shares of Alpha Cognition in the second quarter valued at about $116,000. Berkshire Asset Management LLC PA lifted its holdings in shares of Alpha Cognition by 50.7% in the third quarter. Berkshire Asset Management LLC PA now owns 17,824 shares of the company's stock valued at $116,000 after purchasing an additional 6,000 shares in the last quarter. Finally, Zullo Investment Group Inc. purchased a new stake in shares of Alpha Cognition in the third quarter valued at about $127,000.

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.